Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Fine-Tuning of Routine Combined First- Trimester Screening: The Ratio of Serum-Free- Beta-Human Chorionic Gonadotropin (Fβ Β-Hcg) to Pregnancy-Associated Plasma Protein-A (Papp-A) Could Improve Performance of Down Syndrome Screening Program, a Retrospective Cohort Study in Iran Publisher Pubmed



Younesi S1 ; Amin MMT1 ; Saadati P1 ; Yazdani B2 ; Jamali S1 ; Modarresi MH3 ; Savad S3 ; Amidi S1 ; Ghafourifard S4 ; Razmpoosh E5, 6 ; Yazarlou F3
Authors

Source: Human Antibodies Published:2020


Abstract

OBJECTIVES: To evaluate the performance of the current national screening policy for Down syndrome (DS) in Iran and suggest a more efficient protocol with a wealth of a large series of first-trimester screening (FTS) data obtained from Nilou medical laboratory. To fulfill this aim, detection rate (DR), positive screening rate (PSR), false negative rate (FNR) and odds of being affected given a positive results (OAPR) were calculated at different cutoff risk. In the latest update of DS screening program in Iran, there is no place for intermediate group to be further investigated. Next, we proposed a novel parameter namely the ratio of fβ-hCG multiple of the median (MoM) value to PAPP-A MoM value to delicately categorize FTS results in a way that reduce FNR without imposing unnecessary anxious and extra money on most families. METHODS: The present investigation was conducted retrospectively on 197,210 pregnancies undergoing FTS for aneuploidies in Nilou medical laboratory, Tehran, Iran, from March 2015 to February 2016. RESULTS: Intermediate risk group is important as 23 out of 45 FN fell in the range 1:250 to 1:1100. By applying the proposed index, the ratio of fβ-hCG MoM to PAPP-A MoM and subsequent decision about NIPT, 8 out of 23 FN cases in intermediate group could be detected. CONCLUSION: Compared with the current policy, our novel proposed approach had better performance and could be applied by the Iran National Health Service to improve the screening program guideline. © 2020 - IOS Press and the authors. All rights reserved.
Related Docs
View other Related Docs
1. Uptake and Outcomes of Implementing Non-Invasive Prenatal Testing (Prenatal Reflex Dna Testing) Into First-Trimester Contingent Screening Protocols for Trisomy 21, 18, 13: A Study Protocol, Gene Reports (2024)
2. Various Screening and Diagnosis Approaches for Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes: A Secondary Analysis of a Randomized Non-Inferiority Field Trial, BMJ Open Diabetes Research and Care (2023)
3. Performance of Cell Free Dna As a Screening Tool Based on the Results of First Trimester Screening, Molecular Cytogenetics (2024)
Experts (# of related papers)
View all Related Experts
Sedigheh Hantoushzadeh (5)
Mahboobeh Shirazi (3)
Other Related Docs
4. Screening of Fetal Chromosome Aneuploidies in the First and Second Trimester of 125,170 Iranian Pregnant Women, Iranian Journal of Public Health (2015)
5. Study of Prenatal Screening Tests in Pregnant Women and Comparison With Fetal Karyotype Results, Iranian Journal of Obstetrics# Gynecology and Infertility (2018)
6. Comparative Evaluation Between First and Second Trimester Aneuploidy Screening Tests With Amnio Synthesis Results, Journal of Obstetrics# Gynecology and Cancer Research (2020)
7. Internet-Based Versus Conventional Referral System for Retinopathy of Prematurity Screening in Iran, Ophthalmic Epidemiology (2016)
8. Karyotype Analysis of Amniotic Fluid Cells and Report of Chromosomal Abnormalities in 15,401 Cases of Iranian Women, Scientific Reports (2021)
9. Maternal Fasting Plasma Glucose, Age and Body Mass Index As Prediction of Gestational Diabetes Mellitus in Iran, Iranian Journal of Public Health (2024)
10. Cell-Free Fetal Deoxyribonucleic Acid Results in Low-Risk Pregnancy Screenings for Aneuploidies, Journal of South Asian Federation of Obstetrics and Gynaecology (2018)
11. Maternal Mortality and Its Determining Factors Among Hospitalised Mothers in Tehran, Iran, 2013–2020, Journal of Obstetrics and Gynaecology (2022)
12. Modified Methylated Dna Immunoprecipitation Protocol for Noninvasive Prenatal Diagnosis of Down Syndrome, Journal of Obstetrics and Gynaecology Research (2018)
13. Placental Size and Uterine Artery Doppler for Prediction of Adverse Pregnancy Outcomes in Women With Low Pregnancy-Associated Plasma Protein-A, Shiraz E Medical Journal (2022)
14. Factors Predicting a Positive Pregnancy Screening Test at First Trimester, Tehran University Medical Journal (2021)
15. Maternal Anxiety and the Second-Trimester Prenatal Screening: A Prospective Cohort Study, Fetal Diagnosis and Therapy (2015)
16. Anxiety and Uterine Artery Doppler Flow in a Population of Pregnant Women of High Risk Down Syndrome Fetus: A Prospective Cohort Study, International Journal of Fertility and Sterility (2023)
17. Evaluation of Second-Trimester Maternal Serum Afp Value in the Detection of Congenital Heart Defects, Middle East Journal of Rehabilitation and Health Studies (2021)
18. A Population-Based Prospective Study to Identify Contributors to Mother and Child Health in Suburban Communities: The Cohort Profile, Iranian Journal of Public Health (2018)
19. Association of Cell-Free Fetal Dna at 11-17 Weeks of Pregnancy and the Outcome of Pregnancy, International Journal of Women's Health and Reproduction Sciences (2023)
20. Structures, Processes and Achievements of the National Program of Congenital Hypothyroidism Screening in the Islamic Republic of Iran, Scientific Journal of Kurdistan University of Medical Sciences (2019)